Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Anatagen Pharmaceuticals, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93020C00042 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to Anatagen Pharmaceuticals, Inc. for $599,914.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00014 | Phase I | 599,914 | ||||||||
A SBIR Phase I contract was awarded to Anatagen Pharmaceuticals, Inc. for $599,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800017C-0-0-0 | Phase I | 599,997 | ||||||||
A SBIR Phase I contract was awarded to Anatagen Pharmaceuticals, Inc. for $299,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93022C00011 | Phase I | 299,998 | ||||||||
A SBIR Phase I contract was awarded to Anatagen Pharmaceuticals, Inc. for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93022C00020 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Anatagen Pharmaceuticals, Inc. in August, 2014 for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 200-2014-M-59655 | Phase I | 150,000 | August 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Anatagen Pharmaceuticals, Inc. for $1,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 200-2015-64147 | Phase II | 1,000,000 | ||||||||
A SBIR Phase I contract was awarded to Anatagen Pharmaceuticals, Inc. for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43DA110015 | Phase I | 150,000 |